News

Advanced Molecular Technologies (AMT) is pleased to announce a distribution partnership with Frontier Specialty Chemicals to enhance customer access to AMT’s portfolio of high-purity functionalized PEGs for customers across the US.

Under this arrangement, Frontier Specialty Chemicals will serve as a distribution and customer support partner, providing local sales, order management, and customer service to researchers and organizations seeking access to AMT products. This partnership strengthens AMT’s ability to deliver responsive customer support and efficient product distribution while maintaining the high standards of quality and reliability that customers expect.

With inventory located in the US to avoid customs delays, US customers can access AMT’s high purity compounds and support quicker and easier than before. These high-purity PEGS are available in catalogue and bulk quantities, as well as GMP quality materials to support reliable results from early research through scale-up.

AMT looks forward to working closely with Frontier Specialty Chemicals to provide an improved customer experience and broaden access to our extensive range of PEG compounds and research products.

Advanced Molecular Technologies (AMT) is pleased to announce a collaboration with IDT Australia to provide customers with a streamlined pathway for the development and GMP manufacturing of polyethylene glycol (PEG) linkers. This collaboration was inspired by the increasing requests from AMT customers for GMP grade material.

The collaboration reflects AMT’s ongoing commitment to providing innovative chemistry solutions and expanding access to Australian-developed technologies in international markets. By combining technical expertise, manufacturing capability, and established commercial networks, AMT and IDT Australia able to support the growing requirements of customers across North America, Japan, and other global pharmaceutical markets.

PEG linkers play a critical role in a growing range of advanced therapeutic modalities, including antibody-drug conjugates (ADCs), targeted drug delivery systems, peptide conjugates, and other bioconjugate technologies. As demand for these highly specialised materials continues to grow, the ability to transition seamlessly from research-scale development to GMP-compliant manufacture is increasingly important for pharmaceutical and biotechnology companies.

Through this collaboration, AMT will leverage its extensive expertise in linker chemistry, custom synthesis, process development, and scale-up to support the development of PEG linker technologies from early-stage research through to manufacturing readiness. IDT Australia will provide GMP manufacturing capabilities, analytical testing, quality systems, and regulatory support required for clinical and commercial supply.

For further information regarding PEG linkers, custom synthesis, process development, or GMP manufacturing services, please contact the AMT team.

Advanced Molecular Technologies Pty Ltd (AMT) and Key Organics Limited (Key Organics) today announced that they have entered into an exclusive European supply & marketing agreement.

Within its BIONET brand, Key Organics offers an extensive range of over 65,000 screening compounds, intermediates, building blocks and biochemicals to the international pharmaceutical, biotechnology and agrochemical industries together with the provision of contract chemistry R&D services, process scale-up and manufacture. Key Organics has access to further commercial scale manufacturing through its sister companies within The Tennant Group.

Both companies are embarked on a strategy to increase their range of new and exciting products and technologies such that this partnership makes good strategic sense. Key Organics has access to a global customer base within the global life sciences sector and excellent customer service and compound handling infrastructure that ensures that products are dispatched on the same day.

The agreement between the parties provides for the exclusive, European supply of AMT products by Key Organics. In addition, both companies wish to collaborate in order to further grow their differentiated technology and service offerings within the life sciences sector.